Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DNDN - Dendreon Corp. -- Ignore unavailable to you. Want to Upgrade?

To: brk who wrote (64)	10/13/2000 8:36:54 AM
From: Elmer	Read Replies (1) \| Respond to of 751

Hi brk, I've got a somewhat different take on the secondary offering. If they can sell stock in this market, you own a terrific stock. Remember, a 15% down day doesn't matter if there is nothing wrong with the company. I said in a prior post that if the vaccine works, we won't have to. Let me add that if the vaccine works, the hardest part will be resisting selling your shares into the persistent strength in share price. While I tend to be a trader, if the phase II results out of the Dec. ASH meeting are good, I will try to forget that I own it for fear that I outsmart myself. While this company may not get the science to work, if it does, it will be the best investment of your life.